Ligand validation:3IR5

AGA: (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE

AGA is a Ligand Of Interest in 3IR5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3IR5_AGA_A_1250	53%	39%	0.149	0.94	0.77	1.57	1	2	0	0	83%	0.8333
1Y5I_AGA_C_1309	79%	40%	0.093	0.967	0.76	1.57	1	2	0	0	83%	0.8333
1Y4Z_AGA_A_1309	75%	34%	0.095	0.958	0.93	1.65	1	2	0	0	83%	0.8333
1Y5N_AGA_C_309	63%	39%	0.154	0.95	0.8	1.57	1	3	1	0	100%	1
3IR7_AGA_A_1249	55%	38%	0.142	0.939	0.85	1.54	1	2	0	0	83%	0.8333
1Q16_AGA_A_1309	54%	42%	0.139	0.903	0.74	1.48	1	3	0	0	100%	1
3EGW_AGA_C_309	53%	42%	0.155	0.916	0.74	1.48	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.